Phase I study of autologous T cells bearing fully-humanized chimeric antigen receptors targeting mesothelin in mesothelin- expressing cancers (314)
János L. Tanyi, Andrew R. Haas, Charu Aggarwal, Mark H. O’Hara, Simon F. Lacey, Ryan Golden, Wei‐Ting Hwang, Regina M. Young, Neil C. Sheppard, Steven Albelda, Carl H. June
Topics & Concepts
MesothelinMedicineCartChimeric antigen receptorCohortMesotheliomaInternal medicineGastroenterologyImmunologyOncologyPharmacologyImmunotherapyCancerPathologyMechanical engineeringEngineeringCAR-T cell therapy researchNeuroblastoma Research and Treatments